Plain-English translation of NCT06663137 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing NDV-01 KIT, a new treatment for bladder cancer that is delivered directly into your bladder through a catheter (a thin tube). The treatment combines a gel and a solution, and the trial will check whether it is safe and how well it works to eliminate high-grade bladder cancer in people who are not able to have surgery.
Many patients with high-grade bladder cancer either cannot have surgery to remove their bladder or prefer not to. This medication offers a less invasive option that might help control or eliminate the cancer while preserving the bladder.
You likely qualify if…
You likely don't qualify if…
You will receive the medication through a catheter placed in your bladder every two weeks for the first 10 weeks (six treatments total). About one month later, your doctor will check whether the treatment worked. If it did, you will continue with monthly treatments for the rest of the year. If it did not work completely, you will repeat the initial treatment schedule before moving to monthly maintenance. Some participants will also have blood tests to measure how much medication enters your bloodstream.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
Israel